Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
You can change this under Settings & Account at any time.
Fragile X syndrome
Transcript of Fragile X syndrome
Fragile X Syndrome
Alexis Vick, April Garza, Chheng Ly, Eman Abulalim, Jessica Zamora, Liang-Ying Wei
Fragile X Syndrome- A genetic disorder that causes a range of developmental problems
Fragile X syndrome, also known as Martin-Bell syndrome, was discovered by James Purdon Martin and Julia Bell.
Fragile X syndrome can both genders of all races and ethnicity. It is usually passed through generations but in some cases it is not present in family history.
1 in 4,000 males
1 in 8,000 females
Bailey, D. B., Raspa, M., Olmsted, M. and Holiday, D. B. (2008), Co-occurring conditions associated with FMR1 gene variations: Findings from a national parent survey. Am. J. Med. Genet., 146A: 2060–2069.
Simple, reliable DNA test can identify affected individuals.
Pregnant women are encouraged to test whether or not they are Fragile X carriers.
Majority are still undiagnosed.
Wenstrom, K. D. Fragile X and Other Trinucleotide Repeat Diseases. Obstetrics and Gynecology Clinics of North America. 29: 1367-1376
Permutation-contain 55-200 CGG repeats, no hypermethylation
Full mutation- 200 or more CGG expansion, hypermethylation
Irwin, S. A., Patel, B., Idupulapati, M., Harris, et.(2001), Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination. Am. J. Med. Genet., 98:161-167.
More common in Males
FMR1 can change
Garber, Kathryn B., Visootsak, J., Warren, Stephen T. (2008) Fragile X Syndrome. Eur J Hum Genet 16: 666-672
Penegarikano, O., Mulle, J.G., Warren, S.T. (2007) The Pathophysiology of Fragile X Syndrome. Annu Rev Genomics Hum Genet 8: 108-129
Connective tissue dysplasia
Signs of mental retardation
Avg IQ=40 (adult male)
Shows in >50% of patients
Good sense of humor
Therapeutic/ Psychopharmacological Intervention
Kooy,R.Frank,(2003), Of mice and the fragile X syndrome.Trends in Gentics.19: 148-154.
1. Bailey, D. B., Raspa, M., Olmsted, M. and Holiday, D. B. (2008), Co-occurring conditions associated with FMR1 gene variations: Findings from a national parent survey. Am. J. Med. Genet., 146A: 2060–2069.
2. Garber, Kathryn B., Visootsak, J., Warren, Stephen T. (2008) Fragile X Syndrome. Eur J Hum Genet 16: 666-672.
3. Hagerman, P. J. (2008). The fragile X prevalence paradox. Journal of Medical Genetics, 45, 498−499.
4. Hersh, Joseph H., Saul, Robert A., Committee on Genetics (2011) Health Supervision for Children with Fragile X Syndrome. Pediatrics 127: 994-1006.
5. Myrick, L.M., Nakamoto-Kinoshita, M., Lindor, N.M, Kirmani, S., Cheng, X. Warren, S.T. (2014) Fragile X Syndrome Due to a Missense Mutation. Eur J Hum Genet 22(10): 1185-89.
6. Seltzer, M. M., Baker, M. W., Hong, J., Maenner, M., Greenberg, J., & Mandel, D. (2012). Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 159B(5), 589–597.
7. Wenstrom, K. D. (2009) Fragile X and Other Trinucleotide Repeat Diseases. Obstetrics and Gynecology Clinics of North America. 29: 1367-1376
8. "What Are the Treatments for Fragile X Syndrome?" What Are the Treatments for Fragile X Syndrome? National Institutes of Health, 30 Nov. 2012. Web. 9 Dec. 2014.
9.Schott S, Best L, Bodurtha J 2013 April 25. Fragile X Syndrome. In: Levy H, Lopresti L, and Seibert D, editors. GeneFacts [Internet]. Lutherville, MD: NCHPEG; 2007-2013
Existence of subpopulations
Better method for determining FMRP levels
Need for reliable biomarkers